UiPath (PATH) has been resilient in the face of potential disruption from generative AI. At this point, it is fairly clear that the company isn’t a gen AI winner, but the business is looking rather ...

UiPath delivered a beat-and-raise quarter and was promoted into a midcap index. Shares of automation software company UiPath ...

UiPath Inc. today announced a preview of its upcoming Agent Builder tool as it outlined its vision to combine its expertise in robotic process automation with generative artificial intelligence models ...

UiPath's share price has risen in recent months despite ongoing losses and slow growth. While market conditions are stable, there is still elevated deal scrutiny and longer sales cycles, particularly ...

UiPath stock popped more than 26% on Friday, one day after the company released quarterly earnings that beat Wall Street's top- and bottom-line expectations. Stream NBC 5 for free, 24/7, wherever you ...

The enterprise workflow automation software market presents opportunities driven by digital transformation, demand for ...

UiPath is moving beyond simple, rule-based bots toward "agentic automation." Partnerships are helping to drive scalability of this evolving business. UiPath’s focus on security and transparency could ...

UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...

UiPath helps companies automate tasks traditionally performed by human employees with software robots. The slower-growth ...

Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...